Concepedia

Yuanting Gu

YG

Statistics

Publications

17

Citations

1.1K

H-Index

13

Active since

2015

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Chongqing Medical University

Yuanting Gu is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, molecular oncology, and molecular biology.

ORCID

Publications per year

2015–2021

17

Publications

17

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

Binghe Xu, Min Yan, Fei Ma et al. · The Lancet Oncology · 2021 · 393 citations

, , +16

RETRACTED ARTICLE: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

Mingli Han, Yuanting Gu, Pengwei Lu et al. · Molecular Cancer · 2020 · 192 citations · Full text

, , +17

Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer

Pengwei Lv, Xinguang Qiu, Yuanting Gu et al. · Biomedicine & Pharmacotherapy · 2018 · 88 citations · Full text

, , +17

Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting

Xin Ge, Pengwei Lyu, Zhang Cao et al. · Biochemical and Biophysical Research Communications · 2015 · 85 citations

, , +14

MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways

Mingli Han, Fang Wang, Yuanting Gu et al. · Oncology Reports · 2015 · 53 citations · Full text

, , +16

1–5 of 17